Viking Therapeutics Takeover Target in Biotech Investing?
Investors increasingly ask whether Viking Therapeutics could become a takeover target. This article breaks down why b...
Financial indices provide wider market coverage and reduced single-sector risk versus stock indices. This intro explains practical advantages.
26,745 articlesInvestors increasingly ask whether Viking Therapeutics could become a takeover target. This article breaks down why b...
When Netflix just reported earnings, the market focused on growth signals, margins, and the path to free cash flow. T...
Two clear reasons reasons give cruise line stocks may rebound as travel demand returns and operators strengthen finan...
A synthetic contract puts SpaceX at a $2.4 trillion implied IPO, a figure that dwarfs Facebook's listing and tests ho...
Meta's exploration of renting idle GPU capacity as a cloud resource has sparked a heated, split view on Wall Street. ...
When a meme with Pokémon imagery appeared next to political messaging, it sparked a high-stakes lesson about copyrigh...
CoreWeave surged after its IPO, then pulled back. This guide breaks down how to think about buying the dip, with real...
Prospect Capital offers a striking 20%+ yield, but its long-run performance raises questions. This article lays out a...
Looking a decade ahead, two large, resilient shares stand out. This article explains why NVIDIA and Microsoft are pri...
SpaceX IPO chatter has investors buzzing about windfalls for insiders and thousands of workers with equity. This repo...
Tech giant Alphabet leads a Thursday rally as its Gemini AI rollout gains traction. This piece breaks down what that ...
Choosing between climate-aligned global ETFs and broad international funds can shape your portfolio for years. This g...